Home/Vantive/Peter Rutherford
PR

Peter Rutherford

Head of Worldwide Medical

Vantive

Vantive Pipeline

DrugIndicationPhase
Home Therapy TransformationEnd-Stage Renal Disease (Home Dialysis)Commercial Launch
PrismaLung+ ECCO₂RMild-to-Moderate Acute Respiratory Distress Syndrome (ARDS)Clinical Evidence Generation
Coordinated Care EcosystemsPeritoneal Dialysis Access & SupportClinical Research